[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Oncology Drugs Global Market Report 2018 Including: Blood Cancer; Breast Cancer; Cervical Cancer; Lung Cancer; Colorectal Cancer; Non-Small Cell Lung Cancer ; Prostate Cancer; Kidney Cancer; Gastric Cancer; Brain Tumor; Pancreatic Cancer; Skin Cancer; Ovarian Cancer; Bladder Cancer; Thyroid Cancer; Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma) Covering: F. Hoffmann-La Roche Ltd,Novartis AG,Gilead Sciences Inc,Bayer AG,Takeda Pharmaceticals

February 2018 | 125 pages | ID: OE286EF76CEEN
The Business Research Company

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
If ordered it will be delivered within 3-5 business days.

Oncology Drugs Market Global Report 2018 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global oncology drugs market.

Reasons to Purchase

Reasons to Purchase
  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:

Where is the largest and fastest growing market for the oncology drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The oncology drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider Healthcare market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The oncology drugs market section of the report gives context. It compares the oncology drugs market with other segments of the Healthcare market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Oncology Drugs Indicators Comparison.
Scope

Markets Covered: Blood Cancer; Breast Cancer; Cervical Cancer; Lung Cancer; Colorectal Cancer; Non-Small Cell Lung Cancer ; Prostate Cancer; Kidney Cancer; Gastric Cancer; Brain Tumor; Pancreatic Cancer; Skin Cancer; Ovarian Cancer; Bladder Cancer; Thyroid Cancer; Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)

Companies Mentioned: F. Hoffmann-La Roche Ltd,Novartis AG,Gilead Sciences Inc,Bayer AG,Takeda Pharmaceticals

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Oncology Drugs Indicators Comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

1. ONCOLOGY DRUGS MARKET CHARACTERISTICS

2. ONCOLOGY DRUGS MARKET SIZE AND GROWTH

2.1. Historic Market Growth, Value ($ Billion) and Volume (Million Units)
  2.1.1. Drivers Of The Market
  2.1.2. Restraints On The Market
2.2. Forecast Market Growth, Value ($ Billion)
  2.2.1. Drivers Of The Market
  2.2.2. Restraints On The Market;

3. ONCOLOGY DRUGS TRENDS AND STRATEGIES;

4. PESTLE ANALYSIS

4.1. Political
4.2. Economic
4.3. Social
4.4. Technological
4.5. Legal
4.6. Environmental;

5. ONCOLOGY DRUGS MARKET CUSTOMER INFORMATION;

6. ONCOLOGY DRUGS MARKET REGIONAL AND COUNTRY ANALYSIS

6.1. Global Oncology Drugs Market, 2017, By Region, Value ($ Billion) and Volume (Million Units)
6.2. Global Oncology Drugs Market, 2013 - 2021, Historic And Forecast, By Region
6.3. Global Oncology Drugs Market, Growth And Market Share Comparison, By Region
6.4. Global Oncology Drugs Market, 2017, By Country, Value ($ Billion) and Volume (Million Units)
6.5. Global Oncology Drugs Market, 2013 - 2021, Historic And Forecast, By Country
6.6. Global Oncology Drugs Market, Growth And Market Share Comparison, By Country

7. ONCOLOGY DRUGS MARKET SEGMENTATION

7.1. Global Oncology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Blood Cancer
Breast Cancer
Cervical Cancer
Lung Cancer
Colorectal Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Kidney Cancer
Gastric Cancer
Brain Tumor
Pancreatic Cancer
Skin Cancer
Ovarian Cancer
Bladder Cancer
Thyroid Cancer
Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)
7.2. Global Oncology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

8. ONCOLOGY DRUGS MARKET SEGMENTS

8.1.Blood Cancer
  a) Market Characteristics
  b) Market Trends & Strategies
  c) Global Blood Cancer Market, 2017, By Segment, Value ($ Billion)
8.2.Breast Cancer
  a) Market Characteristics
  b) Market Trends & Strategies
  c) Global Breast Cancer Market, 2017, By Segment, Value ($ Billion)
8.3.Cervical Cancer
  a) Market Characteristics
  b) Market Trends & Strategies
  c) Global Cervical Cancer Market, 2017, By Segment, Value ($ Billion)
8.4.Lung Cancer
  a) Market Characteristics
  b) Market Trends & Strategies
  c) Global Lung Cancer Market, 2017, By Segment, Value ($ Billion)
8.5.Colorectal Cancer
  a) Market Characteristics
  b) Market Trends & Strategies
  c) Global Colorectal Cancer Market, 2017, By Segment, Value ($ Billion)
8.6.Non-Small Cell Lung Cancer
  a) Market Characteristics
  b) Market Trends & Strategies
  c) Global Non-Small Cell Lung Cancer Market, 2017, By Segment, Value ($ Billion)
8.7.Prostate Cancer
  a) Market Characteristics
  b) Market Trends & Strategies
  c) Global Prostate Cancer Market, 2017, By Segment, Value ($ Billion)
8.8.Kidney Cancer
  a) Market Characteristics
  b) Market Trends & Strategies
  c) Global Kidney Cancer Market, 2017, By Segment, Value ($ Billion)
8.9.Gastric Cancer
  a) Market Characteristics
  b) Market Trends & Strategies
  c) Global Gastric Cancer Market, 2017, By Segment, Value ($ Billion)
8.10.Brain Tumor
  a) Market Characteristics
  b) Market Trends & Strategies
  c) Global Brain Tumor Market, 2017, By Segment, Value ($ Billion)
8.11.Pancreatic Cancer
  a) Market Characteristics
  b) Market Trends & Strategies
  c) Global Pancreatic Cancer Market, 2017, By Segment, Value ($ Billion)
8.12.Skin Cancer
  a) Market Characteristics
  b) Market Trends & Strategies
  c) Global Skin Cancer Market, 2017, By Segment, Value ($ Billion)
8.13.Ovarian Cancer
  a) Market Characteristics
  b) Market Trends & Strategies
  c) Global Ovarian Cancer Market, 2017, By Segment, Value ($ Billion)
8.14.Bladder Cancer
  a) Market Characteristics
  b) Market Trends & Strategies
  c) Global Bladder Cancer Market, 2017, By Segment, Value ($ Billion)
8.15.Thyroid Cancer
  a) Market Characteristics
  b) Market Trends & Strategies
  c) Global Thyroid Cancer Market, 2017, By Segment, Value ($ Billion)
8.16.Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)
  a) Market Characteristics
  b) Market Trends & Strategies
  c) Global Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastom  a) Market, 2017, By Segment, Value ($ Billion)

9. GLOBAL ONCOLOGY DRUGS MARKET COMPARISON WITH MACRO ECONOMIC FACTORS

9.1. Oncology Drugs Market Size, Percentage Of GDP, Global
9.2. Per Capita Average Oncology Drugs Expenditure, Global

10. ONCOLOGY DRUGS MARKET COMPARISON WITH MACRO ECONOMIC FACTORS ACROSS COUNTRIES

10.1. Oncology Drugs Market Size, Percentage Of GDP, By Country
10.2. Per Capita Average Oncology Drugs Expenditure, By Country

11. ONCOLOGY DRUGS MARKET COMPARISON WITH INDUSTRY METRICS

11.1. Global Number Of Pharmacists, 2017, By Country
11.2. Global Oncology Market Revenue Versus Number Of Pharmacists, 2017, By Country
11.3. Global Number Of Pharma Enterprises, 2017, By Country
11.4. Global Oncology Market Revenue Versus Number Of Pharma Enterprises, 2017, By Country
11.5. Global Average Spending On R&D/Product Development, 2017, By Country
11.6. Global Oncology Market Revenue Versus Average Spending On R&D/Product Development, 2017, By Country
11.7. Global Generic & Branded Sales Proportion By Country (Value), 2017, By Country
11.8. Global Oncology Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2017, By Country
11.9. Prevalent Cases Of Cancer, 2017, By Country

12. ASIA-PACIFIC ONCOLOGY DRUGS MARKET

  12.1.1. Asia-Pacific Oncology Drugs Market Overview
  12.1.2. Asia-Pacific Oncology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
  12.1.3. Asia-Pacific Oncology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
  12.1.4. Asia-Pacific Oncology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Blood Cancer
Breast Cancer
Cervical Cancer
Lung Cancer
Colorectal Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Kidney Cancer
Gastric Cancer
Brain Tumor
Pancreatic Cancer
Skin Cancer
Ovarian Cancer
Bladder Cancer
Thyroid Cancer
Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)
  12.1.5. Asia-Pacific Oncology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
12.2. Asia-Pacific Oncology Drugs Market: Country Analysis
12.3. China Oncology Drugs Market
  12.3.1. China Oncology Drugs Market Overview
  12.3.2. China Oncology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
  12.3.3. China Oncology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
  12.3.4. China Oncology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Blood Cancer
Breast Cancer
Cervical Cancer
Lung Cancer
Colorectal Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Kidney Cancer
Gastric Cancer
Brain Tumor
Pancreatic Cancer
Skin Cancer
Ovarian Cancer
Bladder Cancer
Thyroid Cancer
Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)
  12.3.5. China Oncology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
12.4. India Oncology Drugs Market
  12.4.1. India Oncology Drugs Market Overview
  12.4.2. India Oncology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
  12.4.3. India Oncology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
  12.4.4. India Oncology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Blood Cancer
Breast Cancer
Cervical Cancer
Lung Cancer
Colorectal Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Kidney Cancer
Gastric Cancer
Brain Tumor
Pancreatic Cancer
Skin Cancer
Ovarian Cancer
Bladder Cancer
Thyroid Cancer
Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)
  12.4.5. India Oncology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  12.5.1. Japan Oncology Drugs Market Overview
  12.5.2. Japan Oncology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
  12.5.3. Japan Oncology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
  12.5.4. Japan Oncology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Blood Cancer
Breast Cancer
Cervical Cancer
Lung Cancer
Colorectal Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Kidney Cancer
Gastric Cancer
Brain Tumor
Pancreatic Cancer
Skin Cancer
Ovarian Cancer
Bladder Cancer
Thyroid Cancer
Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)
  12.5.5. Japan Oncology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
12.6. Australia Oncology Drugs Market
  12.6.1. Australia Oncology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
  12.6.2. Australia Oncology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
  12.6.3. Australia Oncology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Blood Cancer
Breast Cancer
Cervical Cancer
Lung Cancer
Colorectal Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Kidney Cancer
Gastric Cancer
Brain Tumor
Pancreatic Cancer
Skin Cancer
Ovarian Cancer
Bladder Cancer
Thyroid Cancer
Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)
  12.6.4. Australia Oncology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

13. WESTERN EUROPE ONCOLOGY DRUGS MARKET

  13.1.1. Western Europe Oncology Drugs Market Overview
  13.1.2. Western Europe Oncology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
  13.1.3. Western Europe Oncology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
  13.1.4. Western Europe Oncology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Blood Cancer
Breast Cancer
Cervical Cancer
Lung Cancer
Colorectal Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Kidney Cancer
Gastric Cancer
Brain Tumor
Pancreatic Cancer
Skin Cancer
Ovarian Cancer
Bladder Cancer
Thyroid Cancer
Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)
  13.1.5. Western Europe Oncology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
13.2. Western Europe Oncology Drugs Market: Country Analysis
13.3. UK Oncology Drugs Market
  13.3.1. UK Oncology Drugs Market Overview
  13.3.2. UK Oncology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
  13.3.3. UK Oncology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
  13.3.4. UK Oncology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Blood Cancer
Breast Cancer
Cervical Cancer
Lung Cancer
Colorectal Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Kidney Cancer
Gastric Cancer
Brain Tumor
Pancreatic Cancer
Skin Cancer
Ovarian Cancer
Bladder Cancer
Thyroid Cancer
Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)
  13.3.5. UK Oncology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
13.4. Germany Oncology Drugs Market
  13.4.1. Germany Oncology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
  13.4.2. Germany Oncology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
  13.4.3. Germany Oncology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Blood Cancer
Breast Cancer
Cervical Cancer
Lung Cancer
Colorectal Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Kidney Cancer
Gastric Cancer
Brain Tumor
Pancreatic Cancer
Skin Cancer
Ovarian Cancer
Bladder Cancer
Thyroid Cancer
Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)
  13.4.4. Germany Oncology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
13.5 France Oncology Drugs Market
  13.5.1 France Oncology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
  13.5.2 France Oncology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
  13.5.3. France Oncology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Blood Cancer
Breast Cancer
Cervical Cancer
Lung Cancer
Colorectal Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Kidney Cancer
Gastric Cancer
Brain Tumor
Pancreatic Cancer
Skin Cancer
Ovarian Cancer
Bladder Cancer
Thyroid Cancer
Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)
  13.5.4. France Oncology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
13.6. Italy Oncology Drugs Market
  13.6.1. Italy Oncology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
  13.6.2. Italy Oncology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
  13.6.3. Italy Oncology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Blood Cancer
Breast Cancer
Cervical Cancer
Lung Cancer
Colorectal Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Kidney Cancer
Gastric Cancer
Brain Tumor
Pancreatic Cancer
Skin Cancer
Ovarian Cancer
Bladder Cancer
Thyroid Cancer
Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)
  13.6.4. Italy Oncology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
13.7. Spain Oncology Drugs Market
  13.7.1. Spain Oncology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
  13.7.2. Spain Oncology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
  13.7.3. Spain Oncology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Blood Cancer
Breast Cancer
Cervical Cancer
Lung Cancer
Colorectal Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Kidney Cancer
Gastric Cancer
Brain Tumor
Pancreatic Cancer
Skin Cancer
Ovarian Cancer
Bladder Cancer
Thyroid Cancer
Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)
  13.7.4. Spain Oncology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

14. EASTERN EUROPE ONCOLOGY DRUGS MARKET

  14.1.1. Eastern Europe Oncology Drugs Market Overview
  14.1.2. Eastern Europe Oncology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
  14.1.3. Eastern Europe Oncology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
  14.1.4. Eastern Europe Oncology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Blood Cancer
Breast Cancer
Cervical Cancer
Lung Cancer
Colorectal Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Kidney Cancer
Gastric Cancer
Brain Tumor
Pancreatic Cancer
Skin Cancer
Ovarian Cancer
Bladder Cancer
Thyroid Cancer
Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)
  14.1.5. Eastern Europe Oncology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
14.2. Eastern Europe Oncology Drugs Market: Country Analysis
14.3. Russia Oncology Drugs Market
  14.3.1. Russia Oncology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
  14.3.2. Russia Oncology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
  14.3.3. Russia Oncology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Blood Cancer
Breast Cancer
Cervical Cancer
Lung Cancer
Colorectal Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Kidney Cancer
Gastric Cancer
Brain Tumor
Pancreatic Cancer
Skin Cancer
Ovarian Cancer
Bladder Cancer
Thyroid Cancer
Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)
  14.3.4. Russia Oncology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

15. NORTH AMERICA ONCOLOGY DRUGS MARKET

  15.1.1. North America Oncology Drugs Market Overview
  15.1.2. North America Oncology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
  15.1.3. North America Oncology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
  15.1.4. North America Oncology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Blood Cancer
Breast Cancer
Cervical Cancer
Lung Cancer
Colorectal Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Kidney Cancer
Gastric Cancer
Brain Tumor
Pancreatic Cancer
Skin Cancer
Ovarian Cancer
Bladder Cancer
Thyroid Cancer
Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)
  15.1.5. North America Oncology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
15.2. North America Oncology Drugs Market: Country Analysis
15.3. USA Oncology Drugs Market
  15.3.1. USA Oncology Drugs Market Overview
  15.3.2. USA Oncology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
  15.3.3. USA Oncology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
  15.3.4. USA Oncology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Blood Cancer
Breast Cancer
Cervical Cancer
Lung Cancer
Colorectal Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Kidney Cancer
Gastric Cancer
Brain Tumor
Pancreatic Cancer
Skin Cancer
Ovarian Cancer
Bladder Cancer
Thyroid Cancer
Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)
  15.3.5. USA Oncology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

16. SOUTH AMERICA ONCOLOGY DRUGS MARKET

  16.1.1. South America Oncology Drugs Market Overview
  16.1.2. South America Oncology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
  16.1.3. South America Oncology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
  16.1.4. South America Oncology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Blood Cancer
Breast Cancer
Cervical Cancer
Lung Cancer
Colorectal Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Kidney Cancer
Gastric Cancer
Brain Tumor
Pancreatic Cancer
Skin Cancer
Ovarian Cancer
Bladder Cancer
Thyroid Cancer
Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)
  16.1.5. South America Oncology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
16.2. South America Oncology Drugs Market: Country Analysis
16.3. Brazil Oncology Drugs Market
  16.3.1. Brazil Oncology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
  16.3.2. Brazil Oncology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
  16.3.3. Brazil Oncology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Blood Cancer
Breast Cancer
Cervical Cancer
Lung Cancer
Colorectal Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Kidney Cancer
Gastric Cancer
Brain Tumor
Pancreatic Cancer
Skin Cancer
Ovarian Cancer
Bladder Cancer
Thyroid Cancer
Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)
  16.3.4. Brazil Oncology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

17. MIDDLE EAST ONCOLOGY DRUGS MARKET

  17.1.1. Middle East Oncology Drugs Market Overview
  17.1.2. Middle East Oncology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
  17.1.3. Middle East Oncology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
  17.1.4. Middle East Oncology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Blood Cancer
Breast Cancer
Cervical Cancer
Lung Cancer
Colorectal Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Kidney Cancer
Gastric Cancer
Brain Tumor
Pancreatic Cancer
Skin Cancer
Ovarian Cancer
Bladder Cancer
Thyroid Cancer
Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)
  17.1.5. Middle East Oncology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

18. AFRICA ONCOLOGY DRUGS MARKET

  18.1.1. Africa Oncology Drugs Market Overview
  18.1.2. Africa Oncology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
  18.1.3. Africa Oncology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
  18.1.4. Africa Oncology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Blood Cancer
Breast Cancer
Cervical Cancer
Lung Cancer
Colorectal Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Kidney Cancer
Gastric Cancer
Brain Tumor
Pancreatic Cancer
Skin Cancer
Ovarian Cancer
Bladder Cancer
Thyroid Cancer
Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)
  18.1.5. Africa Oncology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

19. ONCOLOGY DRUGS MARKET COMPETITIVE LANDSCAPE

19.1. Company Profiles
19.2. F. Hoffmann-La Roche Ltd
  19.2.1. Overview
  19.2.2. Products And Services
  19.2.3. Strategy
  19.2.4. Financial Performance
19.3. Novartis AG
  19.3.1. Overview
  19.3.2. Products And Services
  19.3.3. Strategy
  19.3.4. Financial Performance
19.4. Gilead Sciences, Inc
  19.4.1. Overview
  19.4.2. Products And Services
  19.4.3. Strategy
  19.4.4. Financial Performance
19.5. Bayer AG
  19.5.1. Overview
  19.5.2. Products And Services
  19.5.3. Strategy
  19.5.4. Financial Performance
19.6. Takeda Pharmaceticals
  19.6.1. Overview
  19.6.2. Products And Services
  19.6.3. Strategy
  19.6.4. Financial Performance

20. KEY MERGERS AND ACQUISITIONS IN THE ONCOLOGY DRUGS MARKET

21. MARKET BACKGROUND: ONCOLOGY DRUGS MARKET

  21.1.1. Oncology Drugs Market Characteristics
  21.1.2. Oncology Drugs Market Historic Growth, Value ($ Billion)
    21.1.2.1. Drivers Of The Market
    21.1.2.2. Restraints Of The Market
  21.1.3. Oncology Drugs Market Forecast Growth, Value ($ Billion)
    21.1.3.1. Drivers Of The Market
    21.1.3.2. Restraints Of The Market
  21.1.4. Oncology Drugs Trends And Strategies
21.2. Oncology Drugs Market Regional And Country Analysis
  21.2.1. Global Oncology Drugs Market, 2017, By Region, Value ($ Billion) and Volume (Million Units)
  21.2.2. Global Oncology Drugs Market, 2013 - 2021, Historic And Forecast, By Region
  21.2.3. Oncology Drugs Market, 2017, By Country, Value ($ Billion) and Volume (Million Units)
  21.2.4. Oncology Drugs Market, 2013 - 2021, Historic And Forecast, By Country
  21.2.5. Oncology Drugs Market, Growth And Market Share Comparison, By Segment
  21.2.6. Oncology Drugs Market, Growth And Market Share Comparison, By Country And Segment
21.3. Global Oncology Drugs Market Comparison With Macro Economic Factors
  21.3.1. Oncology Drugs Market Size, Percentage Of GDP, Global
  21.3.2. Per Capita Average Oncology Drugs Expenditure, Global
21.4. Oncology Drugs Market Comparison With Macro Economic Factors Across Countries
  21.4.1. Oncology Drugs Market Size, Percentage Of GDP, By Country
  21.4.2. Per Capita Average Oncology Drugs Expenditure, By Country
21.5. Key Mergers And Acquisitions In The Oncology Drugs Market

22. APPENDIX

22.1. NAICS Definitions Of Industry Covered In This Report
22.2. Abbreviations
22.3. Currencies
22.4. Research Inquiries
22.5. The Business Research Company
22.6. Copyright And Disclaimer


More Publications